| Compound Information | SONAR Target prediction | | Name: | ESTRADIOL CYPIONATE | | Unique Identifier: | SPE01500283 | | MolClass: | Checkout models in ver1.5 and ver1.0 | | Molecular Formula: | | | Molecular Weight: | 360.276 g/mol | | X log p: | 7.388 (online calculus) | | Lipinksi Failures | 1 | | TPSA | 26.3 | | Hydrogen Bond Donor Count: | 0 | | Hydrogen Bond Acceptors Count: | 3 | | Rotatable Bond Count: | 5 | | Canonical Smiles: | CC12CCC3C(CCc4cc(O)ccc34)C1CCC2OC(=O)CCC1CCCC1 | | Source: | semisynthetic | | Therapeutics: | estrogen |
| Species: |
4932 |
| Condition: |
SWI4 |
| Replicates: |
2 |
| Raw OD Value: r im |
0.5835±0.00968736 |
| Normalized OD Score: sc h |
1.0112±0.0147187 |
| Z-Score: |
0.4816±0.649079 |
| p-Value: |
0.664462 |
| Z-Factor: |
-8.03519 |
| Fitness Defect: |
0.4088 |
| Bioactivity Statement: |
Nonactive |
| Experimental Conditions | | | Library: | SPECMTS3 | | Plate Number and Position: | 18|B5 | | Drug Concentration: | 50.00 nM | | OD Absorbance: | 600 nm | | Robot Temperature: | 26.30 Celcius | | Date: | 2008-02-07 YYYY-MM-DD | | Plate CH Control (+): | 0.042725±0.00146 | | Plate DMSO Control (-): | 0.561525±0.01651 | | Plate Z-Factor: | 0.8863 |
|  png
ps
pdf |
| 3263 |
(3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl)
3-cyclopentylpropanoate |
| 9403 |
[(8S,9S,13S,14S,17S)-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-
yl] 3-cyclopentylpropanoate |
| 19135 |
[(8S,9S,13S,14S,17S)-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-
yl] undecanoate |
| 21070 |
[(8S,9S,13S,14S,17S)-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-
yl] heptanoate |
| 44380 |
(3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl) octanoate |
| 66409 |
[(8S,9S,13S,14S,17S)-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-
yl] decanoate |
| internal high similarity DBLink | Rows returned: 3 | |
|
